GSK plc (LON:GSK)
London
· Delayed Price · Currency is GBP · Price in GBX 1,405.50
+10.50 (0.75%)
Jun 27, 2025, 6:09 PM BST
GSK plc Revenue
GSK plc had revenue of 7.52B GBP in the quarter ending March 31, 2025, with 2.08% growth. This brings the company's revenue in the last twelve months to 31.53B, up 2.57% year-over-year. In the year 2024, GSK plc had annual revenue of 31.38B with 3.46% growth.
Revenue (ttm)
31.53B
Revenue Growth
+2.57%
P/S Ratio
1.80
Revenue / Employee
459.41K
Employees
68,629
Market Cap
56.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
| Indivior | 905.57M |
GSK plc News
- 12 hours ago - GSK Rebranded Flovent Asthma Inahler For Children To Avoid $367 Million Medicaid Rebate, Senator Hassan Accuses - Benzinga
- 17 hours ago - US Senator investigates GSK for pulling children's asthma inhaler - Reuters
- 2 days ago - GSK, Bharat Biotech to slash malaria vaccine prices to under $5 per dose by 2028 - The Times of India
- 2 days ago - Bharat, GSK to halve price of malaria vaccine by 2028 - Reuters
- 3 days ago - GSK gets FDA nod for Benlysta autoinjector in lupus - Seeking Alpha
- 3 days ago - FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis - Business Wire
- 11 days ago - GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US - Business Wire
- 14 days ago - GSK’s RSV vaccine to be reviewed by the EU for expanded use in adults - Seeking Alpha